Since 2008, ARaymondlife concluded an exclusive supplier agreement with Ceva, one of the major world players in the animal health sector, for the production of Prid Delta for a duration of 10 years.
The medication Prid Delta is an intra-vaginal dissemination system produced in bi-material on a polyamide skeleton, molded in EVA (Ethylene Vinyl Acetate) and impregnated with progesterone. Designed to synchronize the estrus of bovines, it provides a controlled release, over 7 days, of the steroid hormone involved in the gestation.
ARaymondlife has made major investments in its Prid Delta manufacturing unit: a dedicated workshop, two automated production lines, and the necessary equipment to ensure complete quality control for each part.
Efforts in the service of customer growth: thanks to the Prid Delta, the Ceva group has won significant international market share in recent years. ARaymondlife produces each year several hundreds of thousands of units for Ceva. A series of technical adaptations have made it possible to keep up with the client and a changing market environment.
A contact first initiated with Ceva in 2002 has forged a sustainable and innovative collaboration. ARaymondlife adapted its injection expertise to the requirements of the veterinary laboratory: the company developed the 3D shape of the device by optimizing its design and ergonomics. Prid Delta incorporates an active ingredient (progesterone) provided by the client in the form of a compound. The precisely controlled bi-material injection process avoids the degradation of the properties of the hormone during processing. This specific business has made ARaymondlife a pioneering pharmaceutical establishment since it offers active ingredient delivery through impregnated matrices, made possible by the process of plastic injection moulding closely linking the polymer and the active molecule.